Compare AbbVie Inc (ABBV) vs Lam Research Corporation (LRCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbbVie Inc vs Lam Research Corporation — how do they compare? AbbVie Inc trades at $250.74 (market cap $439.59B), while Lam Research Corporation trades at $333.3 (market cap $408.07B). The key difference: AbbVie Inc and Lam Research Corporation are close in size by market cap, and AbbVie Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| ABBV | LRCX | |
|---|---|---|
Market Cap | $439.59B | $408.07B |
Sector | Health | Technology |
52-Week High | $263.58 | $433.33 |
52-Week Low | $197.38 | $97.03 |
Enterprise Value | $503.84B | $406.22B |
Dividend Yield | 2.78% | 0.32% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $250.88, up 0.38% on the day, with a bullish technical signal and strong support at $247. The company reported Q2 2026 EPS of $3.65, beating estimates, and maintains robust revenue growth driven by Skyrizi and Rinvoq, offsetting Humira declines. Recent news highlights positive Phase 2 data for ELAHERE in ovarian cancer and institutional stake increases.
Outlook is positive with a consensus price target of $278.69, though high P/E of 70.27 and patent cliffs in the 2030s pose risks. Earnings growth and dividend stability support investor appeal, but regulatory and competitive pressures require monitoring.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →
